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SEROLOGICAL SCREENING FOR  
CELIAC DISEASE IN SYMPTOMATIC  
12 TO 36 MONTH-OLD CHILDREN
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ABSTRACT – Context - The correct diagnosis of celiac disease in environmentally deprived children is frequently hindered by the 
common presence of other causes for the classical celiac disease symptoms: malnutrition, failure to thrive and frequent diarrheas. 
Objectives - To determine the prevalence of celiac disease in a group of 12 to 36 month-old children using immunoglobulin antibodies 
against gliadin (IgG and IgA-AGA), against endomysium (IgA-EMA), and against human tissue transglutaminase (IgA-tTG) as 
screening method. Methods - A total of 214 children (114 boys), aged 12 to 36 months, on gluten-containing diet, were admitted 
to the study. IgG and IgA-AGA, IgA-tTG and IgA-EMA tests were performed in all sera. Biopsy was obtained from all children 
showing positive result in one or more of the serologic tests, excluding those in which IgG-AGA had been the only positive result. 
In those cases, polymerase chain reaction (PCR) HLA genotyping for the identification of celiac disease predisposing alleles was 
applied. HLA genotyping was also performed to confirm the diagnosis in children identified as celiac by means of positive serologic 
testing and compatible biopsy results. Results - Normal results were obtained in 131 children. Ten children out of 68 identified as 
positive exclusively on the IgG-AGA test disclosed the presence of celiac disease predisposing alleles on PCR and underwent jejunal 
biopsy with normal results. All serologic tests were positive in four children. A fifth child showed positive IgG and IgA-AGA and 
IgA-tTG results but disclosed a negative IgA-EMA test. Jejunal biopsy of these five children revealed characteristic lesions of 
celiac disease. Conclusion - A prevalence of 2.3% was found among symptomatic 12- to 36-month-old children that had not been 
previously diagnosed as celiac.
HEADINGS - Celiac disease, diagnosis. Serologic tests. Child.
INTRODUCTION
Celiac disease (CD) is a common multifactorial, 
immuno-mediated enteropathy triggered by the ingestion 
of several related proteins found in wheat (gliadin), 
barley (hordein), and rye (secalin). In genetically 
susceptible individuals the ingestions of these proteins 
leads to infiltration of the intestinal mucosa by both 
intraepithelial CD8+ and lamina propria CD4+ 
lymphocytes that ultimately result in a variable degree 
of jejunal tract lesion(31). 
CD has one of the strongest HLA associations. The 
presence of HLA-DQA1*05 and DQB1*02 alleles, 
either in cis or in trans, which form the HLA-DQ2 
heterodimer, strongly increases the risk for CD. In 
European white population, approximately 90% of 
CD patients have these genetic markers whereas most 
of the remaining cases carry HLA-DQ8 molecules 
coded by the HLA-DQA1*03 and DQB1*0302(19). 
The value of HLA typing in CD is mainly considered 
for its negative predictive value since CD does not 
develop unless a person carries alleles that encode for 
HLA-DQ2 or DQ8(15). 
CD symptomatology is variable and in its classical 
presentation, mostly seen in children, malabsorption 
of nutrients leads progressively to severe malnutrition, 
failure to thrive and diarrheic stools. In adults the clinical 
manifestations of CD are often oligosymptomatic or 
atypical, characterized by abdominal pain, bloating, 
frequents bouts of aftous stomatitis, resistant anemia 
or by an ill defined physical and emotional distress(14). 
This changeable clinical picture, frequently results in 
a delayed diagnosis. Adolescent and young adults 
are, in many instances, free of major symptoms being 
eventually diagnosed during screening studies. The 
timing for the appearance of the first symptoms is 
variable and probably not only related to the gluten 
content of the diet but also to other still unknown 
environmental triggers(7).
CD was originally thought to occur only rarely and 
predominantly in childhood but during the last few 
decades, with the advent of reliable serological testing 
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that allowed large screening studies, a steady worldwide increase 
in its prevalence was noted. Currently CD is recognized as 
a global health problem. Its estimated prevalence in Europe 
and United States has varied from 1:100 to 1:250 both in 
children(5, 17) and in adults(6), and values as high as 1:99 were 
found in children aged 14 to 21 years in Finland(20). Several 
screening studies carried out during the last decade in Brazil 
show a prevalence similar to that found in European countries, 
varying from 1:213 to 1:681 in presumably healthy blood 
donors(12, 22, 23) while other screening studies carried out in 
different Brazilian regions showed frequencies ranging from 
1:53 to 1:417(11, 24, 32).
The aim of this study was primarily to determine the 
prevalence of CD in a group of 12- to 36-month-old symptomatic 
children using antibodies against gliadin, endomysium, and 
recombinant human tissue transglutaminase as screening 
method and, secondarily to call the attention to the difficulties 
in correctly diagnosing CD among socio-economically and 
environmentally deprived children. 
METHODS
This project was approved by the Ethics Committee 
of  the University of  Brasilia School of  Health Sciences, 
Brasilia, DF, Brazil (protocol 051/2003). Children’s parents 
were invited to participate in the study and received written 
and verbal information regarding the objectives, risks, and 
benefits of the study. Children aged 12- to 36-months who 
attended the Pediatric Gastroenterology Unit of the Brasilia 
University Hospital between August 2004 and February 
2007, and were considered at risk for CD were included 
in the study. The Brasilia University Hospital is a general 
hospital, part of the unified government health system that 
attends mainly low-income population living in the periphery 
of the city. Although this population cannot be considered 
deeply disadvantaged by Brazilian standards, the prevalence 
of malnutrition, parasitosis, and infectious diseases is still 
considered high among them, especially during the first 3 
years of life. 
Two hundred and fourteen children were admitted to 
the study (114 boys). The age of  admission varied from 12 
to 36 months (mean and median, 19 months). One hundred 
seventy seven (82.7%) were less than 24 and 37 (17.3%) 
were less than 36 months-old. All children had been on 
gluten-containing diet for at least the previous 6 months. 
The children were considered at risk for CD and included in 
the study when their parents reported: 1) history of  episodes 
of  persistent diarrhea (defined as an increase in frequency 
and liquidity of  stools above the norm for the child, for a 
period of  2 or more weeks); and b) height or weight below 
the 5th percentile.
Serum samples were collected from each participant 
and stored at –20°C until testing. Total immunoglobulin 
A (IgA) level was determined in all sera by turbidimetric 
immunoquantification (COBAS MIRA; Roche Diagnostic 
Systems, Basel, Switzerland). Enzyme-linked immunosorbent 
assay technique (ELISA) was applied to all sera to determine 
IgG and IgA antigliadin (IgG-AGA, IgA-AGA) and IgA 
antitransglutaminase (IgA-tTG) antibody values (Quanta 
Lite IgG and IgA Gliadin and IgA Transglutaminase, 
INOVA Diagnostic Inc., San Diego, CA, USA). The antibody 
concentrations were expressed in arbitrary units (AU), that 
is, percentages of the positive reference serum, and values 
≥20 AU were considered positive. 
Serum IgA-class endomysial antibodies (IgA-EMA) 
were determined by indirect immunofluorescence method. 
Briefly, 4-µm cryostat sections from the distal portion of 
monkey esophagus (INOVA Diagnostic Inc., San Diego, 
CA) were incubated with patients’ sera at a 1:5 dilution. The 
reaction was detected with fluorescein isothiocyanate rabbit 
antihuman IgA conjugate applied to the sections. Under 
the fluorescence microscope, the presence of characteristic 
honeycomb-like brilliant green pattern of smooth muscle 
bundles was interpreted as positive. Children who showed 
positive result in any test underwent repeated testing for 
confirmation of the results.
Small bowel biopsy was suggested to parents of children 
who showed positive results in one or more of the IgA-AGA, 
IgA-EMA and IgA-tTG serologic tests, and in those children 
in whom the only positive test was IgG-AGA but were carriers 
of CD predisposing HLA alleles. The aim of this procedure 
was to avoid unnecessary biopsies in view of the low specificity 
of the IgG-AGA and the strong negative predictive value of 
the absence of HLA predisposing alleles(15). Genomic DNA 
was extracted from peripheral venous blood using the Illustra 
Blood Genomic Prep Mini Spin Kit (GE Healthcare, UK). 
Genotyping for HLA-DQA1*0501, HLA-DQB1*0201 and 
DRB1*04 was processed by the technique of polymerase 
chain reaction-sequence specific primers (PCR-SSP) as 
previously described(27).
Biopsies were performed with a Watson pediatric capsule, 
samples being taken at the level of the ligament of Treitz. 
Biopsy specimens were independently evaluated by a pathologist 
and a pediatric gastroenterologist and assessed according to 
the scoring system described by Marsh(21).
RESULTS
All the 214 children included in the study had normal IgA 
serum levels. Normal results were obtained in all serological 
tests (IgG/IgA-AGA, IgA-EMA and IgA-tTG) in 131 children 
(61.2%). The PCR-SSP of the 68 children whose serologic 
tests results only showed increased level of  IgG-AGA 
disclosed the presence of a predisposing allel in 10. Their 
jejunal biopsies together with those of the 10 children that 
had shown increased levels of both IgG and IgA-AGA with 
normal results on IgA-EMA and IgA-tTG testing, disclosed 
a normal mucosal structure (Marsh 0). Positive IgA-EMA 
test and increased levels of IgG-AGA, IgA-AGA and IgA-
tTG antibodies were found in four children. A fifth child, a 
20-month-old boy, showed abnormal IgG, IgA-AGA and 
IgA-tTG tests but disclosed a negative immunofluorescent 
IgA-EMA. Immunologic and clinical findings in children 
positive on serologic testing can be seen in Table 1.
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Jejunal biopsy of  the five serologic positive children 
disclosed mucosal lesions characterized by a villous flattening, 
crypt hypertrophy and increased number of intraepithelial 
lymphocytes characterizing a CD enteropathy (Marsh III). 
The prevalence of serological and biopsy confirmed cases of 
CD in the present cohort was 1:43 (2.3%). 
DISCUSSION
Among the symptomatic children screened in the present 
study we found a CD prevalence of 5:214 (2.3%). Despite the 
presence of chronic diarrhea, failure to thrive and signs of 
malnutrition, none of these 214 children had been previously 
diagnosed as celiac or had undergone serologic testing to rule 
out the possibility of CD. A disturbing question raised by 
the present findings is how many celiac children, belonging 
to underprivileged segments of society, with varying degrees 
of  chronic gastrointestinal symptoms and malnutrition 
have their diagnosis postponed or worse, could die wrongly 
diagnosed as carrier of environmental enteropathy. This cannot 
be considered an improbable hypothesis as suggested by a 
previous study in which an unexplained age-related variation 
on CD prevalence with a clustering of most cases of CD in the 
younger age group was detected(26). An increased prevalence 
of CD in children when compared to adults is an unexpected 
fact since it is known that CD may start at any age, and being a 
disorder for life, would be expected to have a higher prevalence 
among adults. This difference in prevalence between children 
and adults had already been observed by other authors(10, 33). 
A possible explanation for this fact could be that children, 
especially those born in an adverse environment and exposed 
to a high level of infectious and parasitic agents die as a 
result of early complications without reaching adulthood. 
The mortality rate among undiagnosed symptomatic celiac 
children on a diet containing gluten can be high. Hardwick(16) 
in a pioneer 15-years follow-up study with 70 celiac children, 
published in 1939, reported an overall mortality rate of 36%. 
In the same study this author perceptively observed that 
although there was no difference in the number of CD cases 
between breast-fed and bottle-fed infants, none of the very 
young celiac patients had been breast-fed. Presently, several 
studies are focused on the deleterious consequences of an early 
introduction of gluten in the infant diet and the protective 
effect of breast-feeding(2, 18, 25). Evidences suggest that both 
breast-feeding during the introduction of dietary gluten, 
and increased duration of breast-feeding are associated with 
reduced risk for the development of CD although it is still not 
clear whether breast-feeding delays the onset of symptoms or 
provides a permanent protection against the disease(1). The 
increasing participation of women as workforce in Brazil 
frequently results in an early introduction of inappropriate 
amount and often unfit complementary food and a shorter 
breast-feeding period(8, 18). 
Even when suspected, to confirm a definitive CD diagnosis 
in these environmentally deprived children is not an easy task. 
Besides their poor nutritional status, frequently associated with 
infections and parasitosis, these children can also be affected 
by allergic or even autoimmune disorders resulting in clinical 
conditions that can be indistinguishable from the classical 
presentation of CD in this age group(13). Patient number 
2 (Table 1) is a good example of the difficulty in properly 
diagnosing CD in children subjected to multiple adverse 
environmental factors. This patient was, when initially seen, 
severely malnourished and had a history of persistent diarrhea, 
repetitive bouts of respiratory infections and probable cow’s 
milk intolerance. As shown in Table 1, the child’s IgA-EMA 
was initially tested at the age of 20 months, being negative at 
that time. The child underwent a slow recovery on a gluten 
and milk-free diet. When he was 3 years-old, asymptomatic 
and with weight within normal range for age, to definitively 
establish the diagnosis of CD, a gluten challenge was started 
and serologic tests were repeated after 1 more year of normal 
diet disclosing, at that time, positive IgA-EMA and IgA-tTG 
(101.3U). The diagnosis of CD was confirmed and the child 
was again started on gluten free diet (GFD). It is known 
that in this age group, high levels of antibodies against tTG 
can be present and fluctuate even in non-celiac children(29, 
30). In addition, false positive tTG tests have been eventually 
observed in other inflammatory and autoimmune diseases 
besides CD(3, 9). The histopathologic characteristics of this 
child biopsied sample were compatible with CD but, as 
previously cited, biopsy can be misleading in these children 
as very similar patterns can be seen in children with severe 
malnutrition and repetitive infections of the gastrointestinal 
tract. Figure 1 shows the similarity between this child’s 
biopsy sample (A) and the biopsy sample of a non-celiac 
child suffering from repetitive gastrointestinal infections and 
severe malnutrition (B). 
The fact that his recovery was extremely slow even after the 
institution of a strict GFD reinforced our doubts concerning 
the diagnosis. After the gluten challenge a positive result was 
obtained on this child’s previously negative IgA-EMA test. 
It is a fact that around 20% of infants, mainly below the 
age of 2-years yield false negative results on EMA testing(4). 




Symptoms IgG-AGA IgA-AGA IgA-tTG IgA-EMA Biopsy
1 F 17 Diarrhea, bloating, malnutrition 118.1 196.8 242.7 + Marsh III
2 M 20 Diarrhea, anemia, bloating, malnutrition 142.7 226.2 85.6 _ Marsh III
3 F 26 Diarrhea, RAP, anemia, bloating, malnutrition 86.9 193.4 215.4 + Marsh III
4 F 32 Diarrhea, malnutrition 42.7 99.9 52.9 + Marsh III
5 F 35 Fatigue, anemia, bloating, malnutrition 105.5 61 127.3 + Marsh III
RAP = recurrent abdominal pain
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Modelli IC, Gandolfi L, Almeida RC, Araújo GMAC, Picanço MA, Pratesi R.  Rastreamento sorológico da doença celíaca em crianças sintomáticas 
com 12 a 36 meses de idade.  Arq Gastroenterol. 2010;47(1):61-5.
RESUMO – Contexto - O diagnóstico correto da doença celíaca em crianças ambientalmente carentes é frequentemente dificultado pela presença usual de 
causas outras para os clássicos sintomas da doença celíaca. Objetivo - Determinar a prevalência de doença celíaca em um grupo de crianças com idades 
compreendidas entre 12 e 36 meses, utilizando a pesquisa de anticorpos antigliadina (IgG e IgA-AGA), antiendomísio (IgA-EMA) e antitransglutaminase 
recombinante humana (IgA-tTG) como método de rastreio. Métodos - Foram incluídas no estudo 214 crianças (114 meninos), com 12 a 36 meses 
de idade, todas em uso de dieta contendo glúten. Em todos os soros foi pesquisada a presença de anticorpos anti-IgG e IgA-AGA, anti-IgA-EMA 
e anti-IgA-tTG humana. Biopsia jejunal foi sugerida e efetuada em todas as crianças com resultados positivos em um ou mais testes sorológicos, 
excetuando-se as crianças em que o IgG-AGA tinha sido o único teste positivo. Nesta última situação, efetuou-se genotipagem para identificação 
de possíveis alelos HLA predisponentes por meio do método de PCR. Para confirmação do diagnóstico, a genotipagem dos alelos HLA também foi 
efetuada nas crianças identificadas como celíacas com base a testes sorológicos positivos e resultado da biopsia jejunal compatível. Resultados - Em 
131 crianças os resultados dos testes sorológicos foram normais. Em 68 delas, foi detectada apenas a presença de anticorpos anti-IgG-AGA. Em 10 
destas, por terem apresentado presença de alelos HLA predisponentes, foi realizada biopsia jejunal, que revelou mucosa sem alterações. Todos os 
testes sorológicos foram positivos em quatro crianças. Os testes igG e IgA-AGA e IgA-tTG foram positivos numa quinta criança que, no entanto, 
apresentou teste IgA-EMA negativo. A biopsia jejunal dessas cinco crianças revelou lesões de mucosa típicas e compatíveis com o diagnóstico de 
doença celíaca. Conclusão - Prevalência de 2,3% foi encontrada entre crianças de 12 a 36 meses de idade, não previamente diagnosticadas como celíacas.
DESCRITORES - Doença celíaca, diagnóstico. Testes sorológicos. Criança.
As showed in other studies, the low specificity of  the 
AGA test could once again been observed. This reinforces 
the fact that currently, due to the existence of  the more 
reliable recombinant human tTG and antiendomisyum tests 
the AGA test is only justifiable in those cases in which the 
patient reveals an absolute deficiency of IgA.
In conclusion, in the present study a prevalence of 
2.3% was found among symptomatic 12- to 36-month-old 
FIGURE 1. (A) Jejunal biopsy of patient no. 5, showing villous atrophy, crypta hyperplasia and increased number of intraepithelial lymphocytes 
(>40/100); (B) Jejunal biopsy of a IgA-tTG and IgA-EMA negative non-celiac patient, with infeccious diarrhea caused by enteropatogenic E. coli 0111 
showing a total villous atrophy, cript hyperplasia and increased number of intraepithelial lymphocytes (>40/100)
children that had not been previously diagnosed as celiac. 
This finding reinforce the need of  a careful investigation of 
children belonging to low socio-economic strata and living in 
adverse environmental condition since CD symptomatology, 
in this group of  children, can be easily masked by the 
frequently observed environmental enteropathy that is 
also characterized by malnutrition, failure to thrive and 
persistent diarrhea. 
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